Recent reports have highlighted rare, and sometimes fatal, cases of cerebral venous sinus
thrombosis (CVST) and thrombocytopenia following the Vaxzevria vaccine. An underlying …

Introduction The common reported adverse effects of COVID-19 vaccination consist of the
injection site's local reaction followed by several non-specific flu-like symptoms. However …

To date, billions of vaccine doses have been administered to restrain the current COVID-19
pandemic worldwide. Rare side effects, including intravascular blood clots, were reported in …

Introduction: COVID-19 vaccines became available after being carefully monitored in clinical
trials with safety and efficacy on the human body. However, a few recipients developed …

We report the case of a 50-year-old white man who had always been in good health. He was
a voluntary periodic blood donor (his last whole blood donation was on December 1, 2020) …

Recent reports from the Centers of Disease Control and the US Food and Drug
Administration identified 6 cases of CVST associated with thrombocytopenia in US patients …

Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …

Background and purpose Cerebral venous sinus thrombosis (CVST) has been described
after vaccination against SARS‐CoV‐2. The clinical characteristics of 213 post‐vaccination …

Background: As of 8 April 2021, a total of 2.9 million people have died with or from the
coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021 …

Importance Cases of cerebral venous sinus thrombosis in combination with
thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the …